MSCI

Investors sharpen focus on social and environmental risks to stocks

Pfizer stock was riding high in June 2015, up 128 percent in five years, making it the second-most valuable American drug maker. Nine out of 10 Wall Street research analysts recommended that investors…

Tagged , , Leave a comment